Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)

The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research to advance the diagnosis, management, and treatment of rare diseases. Each Rare Diseases Clinical Research Consortium (RDCRC) will promote highly collaborative, multi-site, patient-centric, translational, and clinical research. The NOFO is expected to be published in winter 2024, with an expected application due date in summer 2024. Some key points about this opportunity include: • The RDCRC will focus on rare diseases and will promote collaborative research. • The NOFO will utilize the U54 activity code, which supports specialized centers through multi-project cooperative agreement awards. • The estimated funding for this opportunity is $1,000,000. • The opportunity is open to various types of applicants, including public and state-controlled institutions of higher education, private institutions of higher education, nonprofits, and for-profit organizations.